What is Inari?
Inari is a pioneering biotechnology firm dedicated to enhancing the sustainability and productivity of the global food supply chain. By leveraging its advanced SEEDesign platform, the company unlocks the full genetic potential of seeds, creating crops that are more resilient and resource-efficient. Positioned at the intersection of life sciences and agricultural technology, Inari addresses critical challenges in food security and environmental health. The company's market position is defined by its ability to bring step-change innovations to the agricultural sector, moving beyond traditional breeding methods to provide high-impact, sustainable alternatives for modern farming.
How much funding has Inari raised?
Inari has raised a total of $757.7M across 8 funding rounds:
Series B
$40M
Series C
$89M
Debt
$45M
Series D
$208M
Series E
$124M
Series F
$103M
Other Financing Round
$144M
Series B (2018): $40M led by Acre Venture Partners, Alexandria Venture Investments, and Flagship Pioneering
Series C (2019): $89M, investors not publicly disclosed
Debt (2020): $45M featuring K2 HealthVentures
Series D (2021): $208M backed by Alexandria Venture Investments, Banque Pictet, Pavilion Capital, Flagship Pioneering, Investment, and G Squared
Series E (2022): $124M with participation from Flagship Pioneering, NGS Super, and CPP Investments
Series F (2024): $103M led by Hanwha Impact Partners, Rivas Capital, CPP Investments, Flagship Pioneering, and NGS Super
Other Financing Round (2025): $144M supported by Hanwha Group, Flagship Pioneering, and ADIA
Key Investors in Inari
Flagship Pioneering
Flagship Pioneering is an American life sciences venture capital company that builds and invests in biotechnology, life sciences, health, and sustainability companies.
Hanwha Group
Hanwha Group is a diversified global conglomerate with interests spanning chemicals, aerospace, and sustainable energy, focusing on quality growth and long-term value creation.
ADIA
The Abu Dhabi Investment Authority (ADIA) is a globally diversified investment institution that manages a broad portfolio of assets to secure long-term financial prosperity.
What's next for Inari?
With the successful closure of this latest capital injection, Inari is well-positioned to accelerate the commercialization of its SEEDesign-enabled products. The strategic focus will likely shift toward scaling operations and expanding the reach of its technology across diverse crop varieties and geographic regions. By maintaining a robust balance sheet, Inari is prepared to navigate the complexities of the agricultural biotech landscape, fostering long-term partnerships and driving the adoption of its sustainable solutions. The company remains committed to its core objective of transforming human health and planetary sustainability through scientific innovation.
See full Inari company page
